Literature DB >> 12807730

CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.

Kishor K Bhakat1, Sankar Mitra.   

Abstract

The mechanism of inactivation of the O6-methylguanine-DNA methyltransferase (MGMT), responsible for repair of mutagenic and cytotoxic O6-alkylguanine, in Mex- tumor cells, is not completely understood. We have examined the role of CpG methylation in the human MGMT promoter in a luciferase (luc) reporter plasmid and associated alteration in chromatin structure. Methylation of 16% CpG sequences in promoter and flanking sequences in the plasmid with HpaII methylase reduced luciferase activity by 10-12-fold, while methylation of all CpG sites, including those in the luc coding sequence, as well as the promoter sequence blocked expression completely. Repression of luc expression due to partial but not complete CpG methylation could be reversed by histone deacetylase inhibitor trichostatin A (TSA). However, 5-azacytidine, which reverses CpG methylation, but not TSA, could reactivate silent MGMT gene in Mex- HeLa MR cells. Furthermore, chromatin immunoprecipitation (ChIP) assay showed reduced level of acetylation of H4 histone bound to the methylated promoter compared with the non-methylated promoter. These results suggest that complete repression of the MGMT gene in Mex- cells requires methylation of CpG sequences in both promoter and neighboring regions of the gene, resulting in inactive, condensed chromatin state of the gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807730     DOI: 10.1093/carcin/bgg086

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

Review 1.  MGMT: a personal perspective.

Authors:  Sankar Mitra
Journal:  DNA Repair (Amst)       Date:  2007-05-07

2.  p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor.

Authors:  Dora Bocangel; Shiladitya Sengupta; Sankar Mitra; Kishor K Bhakat
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

3.  Where are we with treatment options after first line in small cell lung cancer?-report of two opposite cases treated with CAPTEM regimen and possible perspectives.

Authors:  Alessio Cortellini; Antonella Dal Mas; Katia Cannita; Guido Collina; Alessandro Parisi; Francesco Pavese; Giampiero Porzio; Lucilla Verna; Corrado Ficorella
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

4.  Diminished expression of MGMT & RASSF1A genes in gastric cancer in ethnic population of Kashmir.

Authors:  Arif Akbar Bhat; Hilal Ahmad Wani; Ajaz Ahmad Waza; Rawoof Ahmad Malik; Akbar Masood; Showkat Jeelani; Showkat Kadla; Sabhiya Majid
Journal:  J Gastrointest Oncol       Date:  2016-12

5.  Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Henning Leske; Pitt Niehusmann; Lene E Johannessen; Julie Staurseth; Nina Øino; Torstein R Meling; Sverre Heim; Francesca Micci; Petter Brandal
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

6.  Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma.

Authors:  Haiyan Chen; Cuijuan Zhang; Yan Sheng; Shuzhe Yao; Zhiyan Liu; Cheng Zhang; Tingguo Zhang
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 7.  Heat shock proteins and DNA repair mechanisms: an updated overview.

Authors:  Mayra L Sottile; Silvina B Nadin
Journal:  Cell Stress Chaperones       Date:  2017-09-26       Impact factor: 3.667

8.  Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with K-ras G to A mutation in colorectal tumor.

Authors:  Jian Qi; You-Qing Zhu; Mei-Fang Huang; Dong Yang
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

9.  Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.

Authors:  Gaspar J Kitange; Brett L Carlson; Mark A Schroeder; Patrick T Grogan; Jeff D Lamont; Paul A Decker; Wenting Wu; C David James; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2008-10-24       Impact factor: 12.300

10.  Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma.

Authors:  Jonathon F Parkinson; Helen R Wheeler; Adele Clarkson; Catriona A McKenzie; Michael T Biggs; Nicholas S Little; Raymond J Cook; Marinella Messina; Bruce G Robinson; Kerrie L McDonald
Journal:  J Neurooncol       Date:  2007-11-15       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.